[
    [
        {
            "time": "2018-03-13",
            "original_text": "At least four pharma CEOs to testify at Senate drug pricing hearing",
            "features": {
                "keywords": [
                    "pharma CEOs",
                    "testify",
                    "Senate",
                    "drug pricing"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "At least four pharma CEOs to testify at Senate drug pricing hearing",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-13",
            "original_text": "Congress invites 7 drugmakers to testify at potentially hostile hearing on drug prices. Here's what they're saying",
            "features": {
                "keywords": [
                    "Congress",
                    "drugmakers",
                    "testify",
                    "hostile hearing",
                    "drug prices"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Congress invites 7 drugmakers to testify at potentially hostile hearing on drug prices. Here's what they're saying",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 10,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-03-13",
            "original_text": "Flip the Script: Drugmakers Blame Middlemen for Price Increases",
            "features": {
                "keywords": [
                    "Drugmakers",
                    "Blame",
                    "Middlemen",
                    "Price Increases"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Flip the Script: Drugmakers Blame Middlemen for Price Increases",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-13",
            "original_text": "3 Biotech Stocks That Pay Solid Dividends",
            "features": {
                "keywords": [
                    "Biotech Stocks",
                    "Solid Dividends"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotechnology"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "3 Biotech Stocks That Pay Solid Dividends",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 4,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 4,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]